학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 18건 | 목록
1~20
Academic Journal
Wbeimar Aguilar-Jiménez; Lizdany Flórez-Álvarez; Daniel S. Rincón; Damariz Marín-Palma; Alexandra Sánchez-Martínez; Jahnnyer Martínez; María Isabel Zapata; John D. Loaiza; Constanza Cárdenas; Fanny Guzmán; Paula A. Velilla; Natalia A. Taborda; Wildeman Zapata; Juan C. Hernández; Francisco J. Díaz; María T. Rugeles
Biomedica
Biomédica: revista del Instituto Nacional de Salud, Vol 41, Iss Sp. 2, Pp 86-102 (2021)
1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199-207. https://doi.org/10.1056/NEJMoa2001316
2. Chen Y, Liu Q, GuoD . Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418-23. https://doi.org/10.1002/jmv.25681
3. Ortiz ME, Thurman A, Pezzulo AA, Leidinger MR, Klesney-Tait JA, Karp PH, et al. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract. EBioMedicine. 2020;60:102976. https://doi.org/10.1016/j.ebiom.2020.102976
4. Chu H, Chan JFW, Wang Y, Yuen TT, Chai Y, Hou Y, et al. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: An ex vivo study with implications for the pathogenesis of COVID-19. Clin Infect Dis. 2020;71:1400-9. https://doi.org/10.1093/cid/ciaa410
5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
6. Yuan X, Tong X, Wang Y, Wang H, Wang L, Xu X. Coagulopathy in elderly patients with coronavirus disease 2019. AGING Med. 2020;3:260-5. https://doi.org/10.1002/agm2.12133
7. Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57:1-11. https://doi.org/10.1080/10408363.2020.1770685
8. Taborda NA, Hern ndez JC, Montoya CJ, Rugeles MT. Natural killer cells and their role in the immune response during human immunodeficiency virus type-1 infection. Inmunologia. 2014;33:11-20. https://doi.org/10.1016/j.inmuno.2013.11.002
9. Alrubayyi A. NK cells in COVID-19: Protectors or opponents? Nat Rev Immunol. 2020;20:520. https://doi.org/10.1038/s41577-020-0408-0
11. Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity. 2015;42:443-56. https://doi.org/10.1016/j.immuni.2015.02.008
12. Fl rez- lvarez L, Blanquiceth Y, Contreras K, Ossa-Giraldo AC, Velilla PA, Hern ndez JC, et al. NK cell activity and CD57+/NKG2Chigh phenotype are increased in men who have sex with men at high risk for HIV. Front Immunol. 2020;11:1-14. https://doi.org/10.3389/fimmu.2020.537044
13. Zheng M, Gao Y, Wang G, Song G, Liu S, SunD , et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17:533-5. https://doi.org/10.1038/s41423-020-0402-2
14. Sun B, Feng Y, Mo X, Zheng P, Wang Q, Li P, et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect. 2020;9:940-8. https://doi.org/10.1080/22221751.2020.1762515
15. Wang Y, Zhang L, Sang L, Ye F, Ruan S, Zhong B, et al. Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020;130:5235-44. https://doi.org/10.1172/JCI138759
16. Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis. J Intensive Care. 2020;8:1-10. https://doi.org/10.1186/s40560-020-00453-4
17. Centers for Disease Control and Prevention-CDC. Real-time RT-PCR Primers and Probes for COVID-19. Accessed on: April 2, 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html
18. Feria MG, Taborda NA, Hern ndez JC, Rugeles MT. HIV replication is associated to inflammasomes activation, IL-1β, IL-18 and caspase-1 expression in GALT and peripheral blood. PLoS ONE. 2018;13:e0192845. https://doi.org/10.1371/journal.pone.0192845
19. Fl rez- lvarez L, Blanquiceth Y, Ram rez K, Ossa-Giraldo AC, Velilla PA, Hern ndez JC, et al. NK cell activity and CD57+/NKG2Chigh phenotype are increased in men who have sex with men at high risk for HIV. Front Immunol. 2020;11:1-14. https://doi.org/10.3389/fimmu.2020.537044
20.D az FJ, Aguilar-Jim nez W, Fl rez- lvarez L, Valencia G, Laiton-Donato K, Franco-Mu oz C, et al. Aislamiento y caracterizaci n de una cepa temprana de SARS-CoV-2 durante la epidemia de 2020 en Medell n, Colombia. Biom dica. 2020;40(Supl.2):148-58. https://doi.org/10.7705/biomedica.5834
21. Cai Y, Zhang J, Xiao T, Peng H, Sterling SM, Walsh RM, et al. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020;369:1586-92. https://doi.org/10.1126/science.abd4251
22. Gao Y, Yan L, Huang Y, Liu F, Zhao Y, Cao L, et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;368:779-82. https://doi.org/10.1126/science.abb7498
23. Luna OF, G mez J, C rdenas C, Albericio F, Marshall SH, Guzm n F. Deprotection reagents in Fmoc solid phase peptide synthesis: Moving away from piperidine? Molecules. 2016;21:1-12. https://doi.org/10.3390/molecules21111542
24. Perdomo-Celis F, Velilla PA, Taborda NA, Rugeles MT. An altered cytotoxic program of CD8 + T-cells in HIV-infected patients despite HAART-induced viral suppression. PLoS ONE. 2019;14:1-24. https://doi.org/10.1371/journal.pone.0210540
25. Roederer M, Nozzi JL, Nason MC. SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytom Part A. 2011;79:167-74. https://doi.org/10.1002/cyto.a.21015
26. Shi Y, Wang G, Cai X, Deng J, Zheng L, Zhu H, et al. An overview of COVID-19. J Zhejiang Univ Sci B. 2020;21:343-60. https://doi.org/10.1631/jzus.B2000083
27. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39:1011-9. https://doi.org/10.1007/s10096-020-03874-z
28. Garc a LF. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol. 2020;11:4-8. https://doi.org/10.3389/fimmu.2020.01441
29. Azkur AK, Akdis M, AzkurD , Sokolowska M, van de Veen W, Brüggen MC, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy Eur J Allergy Clin Immunol. 2020;75:1564-81. https://doi.org/10.1111/all.14364
30. Ni L, Ye F, Cheng ML, Feng Y, Deng YQ, Zhao H, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52:971-7.e3. https://doi.org/10.1016/j.immuni.2020.04.023
31. Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci USA. 2020;117:9490-6. https://doi.org/10.1073/pnas.2004168117
32. Wang X, Guo X, Xin Q, Pan Y, Hu Y, Li J, et al. Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 in patients and convalescent patients. Clin Infect Dis. 2020;71:2688-94. https://doi.org/10.1093/cid/ciaa721
33. Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200-4. https://doi.org/10.1038/s41591-020-0965-6
34. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71:762-8. https://doi:10.1093/cid/ciaa248
35. Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9:1123-30. https://doi.org/10.1080/22221751.2020.1770129
36. Le Garff-Tavernier M, B ziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas E, et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell. 2010;9:527-35. https://doi.org/10.1111/j.1474-9726.2010.00584.x
37. Kang CK, Han GC, Kim M, Kim G, Shin HM, Song KH, et al. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis. 2020;97:313-21. https://doi.org/10.1016/j.ijid.2020.05.106
38. PayenD , Cravat M, Maadadi H, Didelot C, Prosic L, Dupuis C, et al. A longitudinal study of immune cells in severe COVID-19 patients. Front Immunol. 2020:11:580250. https://doi.org/10.3389/fimmu.2020.580250
39. Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020:130:4694-703. https://doi:10.1172/jci138554
40. Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17:541-3. https://doi.org/10.1038/s41423-020-0401-3
41. De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11:1-17. https://doi.org/10.1038/s41467-020-17292-4
Repositorio UCC
Universidad Cooperativa de Colombia
instacron:Universidad Cooperativa de Colombia
Biomédica, Volume: 41 Supplement 2, Pages: 102-86, Published: 15 OCT 2021
Biomédica: revista del Instituto Nacional de Salud, Vol 41, Iss Sp. 2, Pp 86-102 (2021)
1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199-207. https://doi.org/10.1056/NEJMoa2001316
2. Chen Y, Liu Q, Guo
3. Ortiz ME, Thurman A, Pezzulo AA, Leidinger MR, Klesney-Tait JA, Karp PH, et al. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract. EBioMedicine. 2020;60:102976. https://doi.org/10.1016/j.ebiom.2020.102976
4. Chu H, Chan JFW, Wang Y, Yuen TT, Chai Y, Hou Y, et al. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: An ex vivo study with implications for the pathogenesis of COVID-19. Clin Infect Dis. 2020;71:1400-9. https://doi.org/10.1093/cid/ciaa410
5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
6. Yuan X, Tong X, Wang Y, Wang H, Wang L, Xu X. Coagulopathy in elderly patients with coronavirus disease 2019. AGING Med. 2020;3:260-5. https://doi.org/10.1002/agm2.12133
7. Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57:1-11. https://doi.org/10.1080/10408363.2020.1770685
8. Taborda NA, Hern ndez JC, Montoya CJ, Rugeles MT. Natural killer cells and their role in the immune response during human immunodeficiency virus type-1 infection. Inmunologia. 2014;33:11-20. https://doi.org/10.1016/j.inmuno.2013.11.002
9. Alrubayyi A. NK cells in COVID-19: Protectors or opponents? Nat Rev Immunol. 2020;20:520. https://doi.org/10.1038/s41577-020-0408-0
11. Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity. 2015;42:443-56. https://doi.org/10.1016/j.immuni.2015.02.008
12. Fl rez- lvarez L, Blanquiceth Y, Contreras K, Ossa-Giraldo AC, Velilla PA, Hern ndez JC, et al. NK cell activity and CD57+/NKG2Chigh phenotype are increased in men who have sex with men at high risk for HIV. Front Immunol. 2020;11:1-14. https://doi.org/10.3389/fimmu.2020.537044
13. Zheng M, Gao Y, Wang G, Song G, Liu S, Sun
14. Sun B, Feng Y, Mo X, Zheng P, Wang Q, Li P, et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect. 2020;9:940-8. https://doi.org/10.1080/22221751.2020.1762515
15. Wang Y, Zhang L, Sang L, Ye F, Ruan S, Zhong B, et al. Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020;130:5235-44. https://doi.org/10.1172/JCI138759
16. Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis. J Intensive Care. 2020;8:1-10. https://doi.org/10.1186/s40560-020-00453-4
17. Centers for Disease Control and Prevention-CDC. Real-time RT-PCR Primers and Probes for COVID-19. Accessed on: April 2, 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html
18. Feria MG, Taborda NA, Hern ndez JC, Rugeles MT. HIV replication is associated to inflammasomes activation, IL-1β, IL-18 and caspase-1 expression in GALT and peripheral blood. PLoS ONE. 2018;13:e0192845. https://doi.org/10.1371/journal.pone.0192845
19. Fl rez- lvarez L, Blanquiceth Y, Ram rez K, Ossa-Giraldo AC, Velilla PA, Hern ndez JC, et al. NK cell activity and CD57+/NKG2Chigh phenotype are increased in men who have sex with men at high risk for HIV. Front Immunol. 2020;11:1-14. https://doi.org/10.3389/fimmu.2020.537044
20.
21. Cai Y, Zhang J, Xiao T, Peng H, Sterling SM, Walsh RM, et al. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020;369:1586-92. https://doi.org/10.1126/science.abd4251
22. Gao Y, Yan L, Huang Y, Liu F, Zhao Y, Cao L, et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;368:779-82. https://doi.org/10.1126/science.abb7498
23. Luna OF, G mez J, C rdenas C, Albericio F, Marshall SH, Guzm n F. Deprotection reagents in Fmoc solid phase peptide synthesis: Moving away from piperidine? Molecules. 2016;21:1-12. https://doi.org/10.3390/molecules21111542
24. Perdomo-Celis F, Velilla PA, Taborda NA, Rugeles MT. An altered cytotoxic program of CD8 + T-cells in HIV-infected patients despite HAART-induced viral suppression. PLoS ONE. 2019;14:1-24. https://doi.org/10.1371/journal.pone.0210540
25. Roederer M, Nozzi JL, Nason MC. SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytom Part A. 2011;79:167-74. https://doi.org/10.1002/cyto.a.21015
26. Shi Y, Wang G, Cai X, Deng J, Zheng L, Zhu H, et al. An overview of COVID-19. J Zhejiang Univ Sci B. 2020;21:343-60. https://doi.org/10.1631/jzus.B2000083
27. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39:1011-9. https://doi.org/10.1007/s10096-020-03874-z
28. Garc a LF. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol. 2020;11:4-8. https://doi.org/10.3389/fimmu.2020.01441
29. Azkur AK, Akdis M, Azkur
30. Ni L, Ye F, Cheng ML, Feng Y, Deng YQ, Zhao H, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52:971-7.e3. https://doi.org/10.1016/j.immuni.2020.04.023
31. Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci USA. 2020;117:9490-6. https://doi.org/10.1073/pnas.2004168117
32. Wang X, Guo X, Xin Q, Pan Y, Hu Y, Li J, et al. Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 in patients and convalescent patients. Clin Infect Dis. 2020;71:2688-94. https://doi.org/10.1093/cid/ciaa721
33. Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200-4. https://doi.org/10.1038/s41591-020-0965-6
34. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71:762-8. https://doi:10.1093/cid/ciaa248
35. Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9:1123-30. https://doi.org/10.1080/22221751.2020.1770129
36. Le Garff-Tavernier M, B ziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas E, et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell. 2010;9:527-35. https://doi.org/10.1111/j.1474-9726.2010.00584.x
37. Kang CK, Han GC, Kim M, Kim G, Shin HM, Song KH, et al. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis. 2020;97:313-21. https://doi.org/10.1016/j.ijid.2020.05.106
38. Payen
39. Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020:130:4694-703. https://doi:10.1172/jci138554
40. Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17:541-3. https://doi.org/10.1038/s41423-020-0401-3
41. De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11:1-17. https://doi.org/10.1038/s41467-020-17292-4
Repositorio UCC
Universidad Cooperativa de Colombia
instacron:Universidad Cooperativa de Colombia
Biomédica, Volume: 41 Supplement 2, Pages: 102-86, Published: 15 OCT 2021
Academic Journal
Marín-Palma D; Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, Colombia.; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia UdeA, Medellín, Colombia.; Tabares-Guevara JH; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia UdeA, Medellín, Colombia.; Taborda N; Grupo de Investigaciones Biomédicas Uniremington, Programa de Medicina, Facultad de Ciencias de la Salud, Corporación Universitaria Remington, Medellín, Colombia.; Rugeles MT; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia UdeA, Medellín, Colombia.; Hernandez JC; Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, Colombia. juankhernandez@gmail.com.; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia UdeA, Medellín, Colombia. juankhernandez@gmail.com.
Publisher: BioMed Central Country of Publication: England NLM ID: 101232234 Publication Model: Electronic Cited Medium: Print ISSN: 1476-9255 (Print) Linking ISSN: 14769255 NLM ISO Abbreviation: J Inflamm (Lond) Subsets: PubMed not MEDLINE
Physicochemical Characterization and Evaluation of the Cytotoxic Effect of Particulate Matter (PM10)
Academic Journal
Marin-Palma, Damariz; Gonzalez, Juan D.; Narvaez, Jhon F.; Porras, Jazmin; Taborda, Natalia A.; Hernandez, Juan C.
Academic Journal
Marin-Palma, Maria; Rojas-Sepulveda, Ignacia; Becerra-Caroca, Jessica; Carrasco-Plaza, Jose; Zepeda, Ramiro; Burgos, Pablo Ignacio
Academic Journal
Marín-Palma D; Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, Colombia.; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia (UdeA), Medellín, Colombia.; Tabares-Guevara JH; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia (UdeA), Medellín, Colombia.; Zapata-Cardona MI; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia (UdeA), Medellín, Colombia.; Zapata-Builes W; Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, Colombia.; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia (UdeA), Medellín, Colombia.; Taborda N; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia (UdeA), Medellín, Colombia.; Grupo de Investigaciones Biomédicas Uniremington, Programa de Medicina, Facultad de Ciencias de la Salud, Corporación Universitaria Remington, Medellín, Colombia.; Rugeles MT; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia (UdeA), Medellín, Colombia.; Hernandez JC; Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, Colombia.; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia (UdeA), Medellín, Colombia.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
León K; Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, Colombia. leonbacter@hotmail.com.; Marín-Palma D; Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, Colombia; Grupo de Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. bleidy1122@gmail.com.; Gallego S; Grupo de Investigaciones Biomédicas Uniremington, Programa de Medicina, Facultad de Ciencias de la Salud, Corporación Universitaria Remington, Medellín, Colombia. salomon.sgq@gmail.com.; Yepes C; Grupo de Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. cristinaypz0@gmail.com.; Vélez J; Grupo de Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. jhonatan-2611@hotmail.com.; Castro GA; Grupo de Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. gustavoandresc@gmail.com.; Jaimes F; Dirección de Investigaciones, Fundación Hospitalaria San Vicente de Paúl, Medellín, Colombia; Departamento de Medicina Interna, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. fabian.jaimes@udea.edu.co.; Taborda N; Grupo de Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia; Grupo de Investigaciones Biomédicas Uniremington, Programa de Medicina, Facultad de Ciencias de la Salud, Corporación Universitaria Remington, Medellín, Colombia. natalia.taborda@uniremington.edu.co.; Rugeles MT; Grupo de Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. maria.rugeles@udea.edu.co.; Hernández JC; Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, Colombia. juankhernandez@gmail.com.
Publisher: Instituto Nacional de Salud Country of Publication: Colombia NLM ID: 8205605 Publication Model: Electronic Cited Medium: Internet ISSN: 2590-7379 (Electronic) Linking ISSN: 01204157 NLM ISO Abbreviation: Biomedica Subsets: MEDLINE
Academic Journal
Marín-Palma D; Grupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, 050012 Medellín, Colombia.; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, UdeA, 050010 Medellín, Colombia.; Tabares-Guevara JH; Grupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, 050012 Medellín, Colombia.; Zapata-Cardona MI; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, UdeA, 050010 Medellín, Colombia.; Flórez-Álvarez L; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, UdeA, 050010 Medellín, Colombia.; Yepes LM; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, UdeA, 050010 Medellín, Colombia.; Rugeles MT; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, UdeA, 050010 Medellín, Colombia.; Zapata-Builes W; Grupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, 050012 Medellín, Colombia.; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, UdeA, 050010 Medellín, Colombia.; Hernandez JC; Grupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, 050012 Medellín, Colombia.; Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, UdeA, 050010 Medellín, Colombia.; Taborda NA; Grupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, 050012 Medellín, Colombia.; Grupo de Investigaciones Biomédicas Uniremington, Programa de Medicina, Facultad de Ciencias de la Salud, Corporación Universitaria Remington, 050016 Medellín, Colombia.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE
Academic Journal
Marin-Palma, Damariz; Fernandez, Geysson Javier; Ruiz-Saenz, Julian; Taborda, Natalia A.; Rugeles, Maria T.; Hernandez, Juan C.
Academic Journal
Academic Journal
Aguilar-Jiménez, Wbeimar; Flórez-Álvarez, Lizdany; Rincón, Daniel S.; Marín-Palma, Damariz; Sánchez-Martínez, Alexandra; Martínez, Jahnnyer; Isabel Zapata, María; Loaiza, John D.; Cárdenas, Constanza; Guzmán, Fanny; Velilla, Paula A.; Taborda, Natalia A.; Zapata, Wildeman; Hernández, Juan C.; Díaz, Francisco J.; Rugeles, María T.
Academic Journal
Castro, Gustavo; León, Kevin; Marín-Palma, Damariz; Oyuela, Sarita M.; Cataño-Bedoya, Jhon Ubeimar; Duque-Botero, Julieta; Giraldo-Méndez, Diana Patricia; Taborda, Natalia A.; Hernandez, Juan C.; Rugeles, María Teresa; Jaimes, Fabián Alberto
Academic Journal
Marín-Palma D; Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, Colombia.; Grupo Inmunovirologia, Facultad de Medicina, Universidad de Antioquia, UdeA, Medellín, Colombia.; Castro GA; Grupo Inmunovirologia, Facultad de Medicina, Universidad de Antioquia, UdeA, Medellín, Colombia.; Cardona-Arias JA; Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, Colombia.; Escuela de Microbiología, Universidad de Antioquia, UdeA, Medellín, Colombia.; Urcuqui-Inchima S; Grupo Inmunovirologia, Facultad de Medicina, Universidad de Antioquia, UdeA, Medellín, Colombia.; Hernandez JC; Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, Colombia.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE
Academic Journal
Academic Journal
Castro MD, MSc, Gustavo; León MSc, Kevin; Marín-Palma MSc, Damariz; Oyuela MD, Sarita M.; Cataño-Bedoya MD, Esp, Jhon Ubeimar; Duque-Botero MD, Esp, Julieta; Giraldo-Méndez MD, Esp., Diana Patricia; Taborda Sci Doc, Natalia A.; Hernandez Sci Doc, Juan C.; Rugeles Sci Doc, María Teresa; Jaimes MD, Esp., MSC, PhD, Fabián Alberto
Revista Ciencias de la Salud, Volume: 19, Issue: 3, Pages: 55-72, Published: 03 MAY 2022
Academic Journal
Academic Journal
In: Revista Ciencias de la Salud . (Revista Ciencias de la Salud, 2019, 17(2):245-258)
Academic Journal
In: Iatreia . (Iatreia, October-December 2017, 30(4):423-435)
Dissertation/ Thesis
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Universidad Autónoma de Madrid
instname
Universidad Autónoma de Madrid
검색 결과 제한하기
제한된 항목
[검색어] Marín-Palma, D.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어